Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2022
∙
NACI
Updated guidance on a first booster dose of COVID-19 vaccines in Canada
2022
∙
NACI
Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age
2022
∙
ACIP
Updates from the Pneumococcal Vaccines Work Group
2022
∙
Sara Oliver, ACIP
Updates to the Evidence to Recommendation Framework: Pfizer-BioNTech COVID-19 booster in children aged 5-11 years
2022
∙
ACIP
Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices
2022
∙
ACIP
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices
2022
∙
Conseil Supérieur de la Santé (CSS)
Vaccination against seasonal influenza: winter season 2022-2023 in Belgium
2022
Vaccination recommendations in response to the current monkeypox outbreak
2022
∙
Haute Autorité de Santé
Vaccination strategy against Covid-19 - Place of the NUVAXOVID vaccine (NVX-CoV2373)
2022
∙
Commission Technique des Vaccinations, Haute Autorité de Santé
Vaccination strategy against Covid-19 – Anticipation of potential scenarios in the fall of 2022 in France
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
